The global veterinary in vitro fertilization (IVF) market is experiencing steady growth, driven by increasing demand for advanced reproductive technologies in animal breeding and livestock management. The rising need to enhance genetic quality, improve fertility rates, and support sustainable animal agriculture is pushing the adoption of IVF procedures in both commercial livestock and companion animals. Technological advancements in embryo transfer techniques, cryopreservation, and fertility monitoring are further propelling the market, while growing awareness of reproductive health in animals is influencing veterinary practices globally.
Global Veterinary in Vitro Fertilization (IVF) Market size was valued at USD 1.80 billion in 2024 and is projected to reach USD 2.76 billion by 2032, with a CAGR of 5.50% during the forecast period of 2025 to 2032.
To know more, visit https://www.databridgemarketresearch.com/reports/global-veterinary-ivf-market
Below are the Top Veterinary In Vitro Fertilization (IVF) Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Zoetis Services LLC
|
Zoetis Services LLC is a leading global animal health company specializing in the development, manufacturing, and marketing of veterinary vaccines, medicines, and diagnostic products. The company plays a significant role in the veterinary IVF market through its advanced reproductive technologies and fertility solutions designed to improve livestock productivity and animal health. With a strong focus on innovation, Zoetis provides products and services that support embryo transfer, artificial insemination, and fertility monitoring, contributing to the growth of the veterinary IVF sector.
|
|
North America, South America, Middle East and Africa, Asia-Pacific, and Europe
|
In September 2024, Zoetis and Danone announced a strategic partnership to enhance sustainability in dairy farming through genetics. By combining their expertise, they aimed to improve animal health, reduce environmental impact, and create resilient dairy herds, aligning with growing consumer demand for sustainable dairy products.
|
|
2.
|
Esco Medical
|
Esco Medical, a division of the Esco Group, is a prominent manufacturer of medical equipment specializing in advanced IVF technologies and laboratory solutions. While primarily focused on human assisted reproduction, Esco Medical’s cutting-edge incubators, time-lapse monitoring systems, and workstations are also used in veterinary IVF procedures. The company's commitment to precision and innovation ensures high success rates in embryo development, positioning Esco Medical as a key player in both human and animal reproductive technology markets.
|
|
North America and Europe
|
In October 2024, Esco Medical launched the MIRI Laminar Flow (MLF) Cabinet, designed for IVF clinics and laboratories. This innovative cabinet utilized vertical airflow and advanced filtration to ensure optimal sample protection, safety, and efficiency in laboratory environments.
|
|
3.
|
Minitube
|
Minitube is a global leader in reproductive technologies for animal breeding, offering a comprehensive range of products and services for artificial insemination, embryo transfer, and IVF. The company provides state-of-the-art equipment for semen analysis, cryopreservation, and embryo culture, catering to various species including cattle, swine, and equines. With a strong emphasis on research and development, Minitube continues to drive advancements in veterinary reproductive health, supporting the growing demand for efficient and effective IVF solutions.
|
Maturation medium for oocytes TCM 199 stock solution, 20 ml
|
North America, South America, Middle East, Asia-Pacific, and Europe
|
|
|
4.
|
IMV Technologies Group
|
IMV Technologies Group is a pioneering company in the field of animal reproductive biotechnologies, offering a wide array of products for artificial insemination, embryo transfer, and IVF. The company’s solutions are widely used in livestock breeding, contributing to improved fertility rates and genetic diversity. IMV Technologies’ focus on innovation and sustainability has made it a trusted name in veterinary reproductive health, with a global presence that supports the expanding veterinary IVF market.
|
|
North America, South America, Asia-Pacific, and Europe
|
In September 2024, IMV Technologies Group acquired UD-Vet B.V. UD-Vet are a leading provider of Veterinary practice equipment and other veterinary imaging modalities, based in Utrecht, Netherlands and Brussels, Belgium with a reach throughout the Benelux region.
|
|
5.
|
Hamilton Thorne, Inc.
|
Hamilton Thorne, Inc. is a leading provider of precision instruments and laboratory equipment for reproductive technologies, including IVF. While primarily focused on human applications, Hamilton Thorne’s advanced imaging systems, laser technologies, and micromanipulation tools are also employed in veterinary IVF procedures. The company’s emphasis on high-quality, reliable solutions has positioned it as a key player in the reproductive technology market, contributing to advancements in both human and veterinary fertility treatments.
|
|
North America, South America, Middle East and Africa, Asia-Pacific, and Europe
|
In October 2023, Hamilton Thorne Ltd. has acquired Gynetics Medical Products N.V., enhancing its consumables portfolio in the European IVF market. This strategic acquisition increases recurring revenue opportunities and expands product offerings, reinforcing Hamilton Thorne’s commitment to high-quality assisted reproductive technologies.
|
Conclusion
The global veterinary in vitro fertilization (IVF) market is poised for continued growth, fueled by increasing demand for advanced reproductive technologies to enhance animal breeding and genetic quality. While high procedural costs and limited access in certain regions present challenges, ongoing technological advancements in embryo transfer, cryopreservation, and fertility monitoring are driving widespread adoption. The growing focus on sustainable livestock management and animal productivity, combined with innovations from key industry players, ensures a promising future for the veterinary IVF market across both developed and emerging markets.
